Northwind Pharmaceuticals

A Flu Shot in the Dark

A-Flu-Shot-in-the-DarkAlong with all the joy and celebration this time of year brings comes one very unwelcome guest: the flu. Flu seasons are always changing and the infection can present itself in people differently. The best way to protect from the flu is with a vaccine.

What kinds of vaccines are available?

According to the Center for Disease Control and Prevention, “traditional flu vaccines made to protect against three different flu viruses (called “trivalent” vaccines) are available. In addition, flu vaccines made to protect against four different flu viruses (called “quadrivalent” vaccines) also are available.

Trivalent flu vaccine protects against two influenza A viruses (an H1N1 and an H3N2) and an influenza B virus. The following trivalent flu vaccines are available:

  • Standard-dose trivalent shots (IIV3)
  • An intradermal trivalent shot.
  • A high-dose trivalent shot, approved for people 65 and older.
  • A trivalent shot containing virus grown in cell culture
  • A recombinant trivalent shot that is egg-free

The quadrivalent flu vaccine protects against two influenza A viruses and two influenza B viruses. The following quadrivalent flu vaccines are available:

  • A quadrivalent flu shot.
  • A quadrivalent nasal spray vaccine, approved for people 2 through 49 years of age”

So how do you know which ones to choose?

There is not one vaccine recommended over another, according to the CDC, with one exception.  “Starting in 2014-2015, CDC recommends use of the nasal spray vaccine for healthy children 2 years through 8 years of age” For more information on flu vaccines, check out these Flu Facts from the CDC.

Northwind Pharmaceuticals is your partner when it comes to choosing the right medication for dispensing. Contact us today to learn how our solutions can help you take out the guess work and effectively dispense with confidence.

Schedule a free claims analysis now.

Let’s Talk now

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading

Stewardship and the Beauty of Health Benefits

Phillip Berry | Oct 25th, 2024
The Beauty of Making a Difference Beauty in health benefits? What does that even mean? Think back on your experience as an HR/benefits professional. What are the peak moments? Most would agree that the high points are moments when they see their work directly impacting an employee or plan member. A time when the health … more »

continue reading